USFDA inspects Neuland Laboratories’ Unit 2 manufacturing facility in Telangana

03 May 2025 Evaluate

The United States Food and Drug Administration (USFDA) has inspected Neuland Laboratories’ Unit 2 manufacturing facility, located at Pashamylaram village, Sangareddy District, in Telangana from April 28, 2025 to May 2, 2025.

The FDA issued Form 483, with one observation related to building and facility management, which the company will respond to within the stipulated timelines.

Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs.


Neuland Laboratories Share Price

13502.00 334.15 (2.54%)
22-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1374.60
Zydus Lifesciences 883.85
Lupin 2165.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×